Influence of acarbose (a glucosidase inhibitor) on experimental atherosclerosis in the rabbit

Artery. 1990;17(3):170-5.

Abstract

Acarbose, a complex oligosaccharide of microbial origin, was added at levels of 100, 200 or 400 mg/kg to an atherogenic diet fed to New Zealand White rabbits. The rabbits consumed 75 g/day of each diet, thus the daily intake of Acarbose was 7.5, 15 and 30 mg. Rabbits fed 30 mg/day of Acarbose showed reduced levels of plasma cholesterol, intermediate density lipoprotein (IDL) and low density lipoprotein (LDL). Aortic sudanophilia was inhibited by 23% in rabbits fed 7.5 mg/day of Acarbose and by 43% in rabbits fed 15 or 30 mg/day. Acarbose had been shown previously to lower serum cholesterol and triglyceride levels in rats and mice. Our studies demonstrate that it also inhibits atherogenesis in rabbits fed 0.2% cholesterol.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acarbose
  • Animals
  • Arteriosclerosis / etiology
  • Arteriosclerosis / prevention & control*
  • Cholesterol / blood
  • Diet, Atherogenic
  • Glycoside Hydrolase Inhibitors*
  • Lipoproteins / blood
  • Liver / drug effects
  • Male
  • Organ Size / drug effects
  • Phospholipids / metabolism
  • Rabbits
  • Triglycerides / metabolism
  • Trisaccharides / therapeutic use*
  • Weight Gain / drug effects

Substances

  • Glycoside Hydrolase Inhibitors
  • Lipoproteins
  • Phospholipids
  • Triglycerides
  • Trisaccharides
  • Cholesterol
  • Acarbose